In-Vitro Diagnostics World Market 2018-2028 - Visiongain Report

LONDON, September 12, 2018 /PRNewswire/ --

Point of Care, Clinical Chemistry, Immunochemistry, Haematology, Microbiology, Molecular Diagnostics, Flow Cytometry, Infectious Diseases, Diabetes, Cardiology, Autoimmune Diseases, Renal Diseases, Pharmacogenomics, HIV/AIDS, Reagent & Kits, Instruments, Data Management Software & Services, Hospitals, Laboratories, Home Care Testing, Research Institutes, Blood Glucose Testing, Infectious Disease Testing, Rapid Coagulation Testing,Cholesterol Testing, Pregnancy Testing, Basic Metabolic Panel, Electrolyte Panel, Liver Profile, Lipid Profile, Thyroid Function Test, ELISA, Immuno-PCR, Rapid Test, Western Blot, Enzyme linked Immunospot Assay

     (Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

The revenue of the in-vitro diagnostics market in 2017 was estimated at $63bn and was dominated by the Point of Care Testing Segment. The Molecular Diagnostics segment will be the fastest growing segment in the first-half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 263-page report you will receive 107 tables and 81 figures- all unavailable elsewhere.

The 263-page report provides clear detailed insight into the in-vitro diagnostics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• In-Vitro Diagnostics market forecasts from 2018-2028

• This report breaks down the revenue forecast for the main submarkets by Type:
• Point of care
• Clinical chemistry
• Immunochemistry
• Haematology
• Microbiology
• Molecular Diagnostics
• Flow Cytometry
• Others

• The Point of Care Diagnostic submarket is further segmented into:
• Blood Glucose Testing
• Infectious Disease Testing
• Rapid Coagulation Testing
• Cholesterol Testing
• Pregnancy Testing

• The Clinical Chemistry submarket is further segmented into:
• Basic Metabolic Panel
• Electrolyte Panel
• Liver Profile
• Lipid Profile
• Thyroid Function Test

• The Immunochemistry submarket is further segmented into:
• ELISA
• Immuno-PCR
• Rapid Test
• Western Blot
• Enzyme linked Immunospot Assay

• This report breaks down the revenue forecast for the main submarkets by Application:
• Infectious Diseases
• Diabetes
• Cardiology
• Autoimmune Diseases
• Renal Diseases
• Pharmacogenomics
• HIV/AIDS
• Other Applications

• This report breaks down the revenue forecast for the main submarkets by Products & Services:
• Analyzers
• Reagents
• Software & Services

• This report breaks down the revenue forecast for the main submarkets by End-User:
• Lab Testing
• Hospital Testing
• University Testing
• Home Care Testing

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• Americas: US, Canada, Mexico, Brazil, Rest of Americas
• Europe: UK, Germany, France, Spain, Italy, Russia, Rest of Europe
• Asia: India, China, Japan, Rest of Asia
• RoW

Each regional and national market is further segmented by type.

• Our study includes SWOT analysis and STEP analysis of the in-vitro diagnostics market.

• Our study discusses the selected leading companies that are the major players in the in-vitro diagnostics market:
• Abbott Diagnostics
• Agilent Technologies
• Becton, Dickinson and Company (BD)
• BioMerieux
• Bio-Rad
• Danaher Corporation
• DiaSorin Diagnostics s.p.a
• Roche Diagnostics
• Siemens Diagnostics
• Sysmex Corporation

Visiongain's study is intended for anyone requiring commercial analyses for the in-vitro diagnostics market. You find data, trends and predictions.

Buy our report today In-Vitro Diagnostics World Market 2018-2028: Point of Care, Clinical Chemistry, Immunochemistry, Haematology, Microbiology, Molecular Diagnostics, Flow Cytometry, Infectious Diseases, Diabetes, Cardiology, Autoimmune Diseases, Renal Diseases, Pharmacogenomics, HIV/AIDS, Reagent & Kits, Instruments, Data Management Software & Services, Hospitals, Laboratories, Home Care Testing, Research Institutes, Blood Glucose Testing, Infectious Disease Testing, Rapid Coagulation Testing, Cholesterol Testing, Pregnancy Testing, Basic Metabolic Panel, Electrolyte Panel, Liver Profile, Lipid Profile, Thyroid Function Test, ELISA, Immuno-PCR, Rapid Test, Western Blot, Enzyme linked Immunospot Assay

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website : https://www.visiongain.com/report/in-vitro-diagnostics-world-market-2018-2028/

3M
Abbott Laboratories
AbbVie
AccuQuik
ACON Laboratories
Adaltis
AdnaGen AG
Affymetrix
Agendia
Agilent
Akonni Biosystems
Alere 
Amgen
Apogee Flow Systems Ltd.
Arkay
AssuraGen
Assurex Health, Inc.
Astute Medical
Atlas Genetics
B.Braun
Bayer
Beckman Coulter
Binding Site
Biohit HealthCare
Biokit S.A
bioMérieux
Bio-Rad
BioStar
BioSystems
Bio-Techne
bioTheranostics
Bristol Myers-Squibb
CardioGenics
Caribou Biosciences
Celerus Diagnostics
Cepheid
Claros Diagnostics
Compendia Bioscience
Corgenix
Crescendo Bioscience
Dako
Danaher
Daxor Corporation
Dexcom
DiaGenic
Diagnostics for Real World
DiaSorin
Diaxonhit
Diazyme Laboratories
Editas Medicine
Exosome Diagnostics
Expedeon
Expression Diagnostics
Focus Diagnostics
Fujirebio Diagnostics Inc.
GE Healthcare
Gene Chip Research Centre, Tianjin, China
Genentech
GenMark Diagnostics
Genomic Health
Gen-Probe
Glycominds
Haemonetics Corporation
Hai Kang Life Corporation
Helena Laboratories
HemoCue
Hologic
Human Genetics Commission
Immucell
Immucor
Innogenetics
Innova Biosciences
Innova Biotechnology Co.
Instrumentation Laboratory
Intec
Intellia Therapeutics, Inc.
Ipsogen
Janssen Biotech
Janssen Pharmaceuticals
Johnson & Johnson 
Kreatech Diagnostics
Lab-21
LabIndia
Launch Diagnostics
Leica Microsystems
Life Technologies
LifeScan
Luminex
Med BioGene
Melanoma Diagnostics
Meridian Bioscience
Milagen
Miltenyi Biotec
Mindray
Miraca Life Sciences
Myriad Genetics
mySugr GmbH
Nanosphere
Neo New Oncology
Nova Biomedical
Novartis
Novatein Biosciences
Onconome
OraQuick
Orion Genomics
Ortho Clinical Diagnostics
PathWorks Diagnostics
PerkinElmer
Phillips
Polymedco
Polymer Technology Systems, Inc.
Precipio
Qiagen 
Quest Diagnostics
Quidel
Radiometer Medical
Randox Laboratories
Recombinetics, Inc.
Response Biomedical
Roche
Rules-Based Medicine
Saladax Biomedical
Sangamo
Sanofi
SDIX 
Sekisui Diagnostics
Sera Prognostics
SeraCare Life Sciences
Siemens
Siemens Healthineers
Sigma Aldrich Corporation
Span Diagnostics
Stago
STARLIMS Technologies
SterilMed
Stratedigm, Inc.
Suzhou Ribo Life Sciences
Synthes
Sysmex
Target Discovery
Targeted Diagnostics & Therapeutics
Tem International GmbH
Tethys Bioscience
Thermo Fisher Scientific
Tocagen
Tosoh Bioscience
Transasia Bio Medicals
Trinity Biotech
UroSens
VentriPoint
Verax Biomedical 
Vermillion
Viewics, Inc.
ViiV Healthcare 
Ypsomed

To see a report overview please e-mail Sara Peerun on [email protected]

SOURCE Visiongain